We have published more than one hundred original articles, invited reviews and editorials in leading medical journals.
Supervised by Karl Lemström:
Alexey Dashkevich, MD, PhD. 2016. Lymphatic Endothelium in Terminal Heart Failure and after Heart and Lung Transplantation. Opponent Professor Fadi Lakkis, University of Pittsburgh, PA.
Jussi Ropponen, MD, PhD. 2015. Innate Immune Responses in Obliterative Bronchiolitis After Lung Transplantation - The Role of Statins and Hypoxia-Inducible Factor-1. Opponent Professor Shaf Keshavjee, University of Toronto, Toronto, Canada.
Simo Syrjälä, MD, PhD. 2014. Critical role of angiopoietin pathway in ischemia-reperfusion injury in cardiac transplantation. Opponent Professor Daniel Goldstein, Yale School of Medicine, New Haven, CT.
Raimo Tuuminen, MD, PhD. 2014. Microvascular dysfunction in ischemia-reperfusion in cardiac and kidney allografts. Opponent Professor Joren Madsen, Harvard Medical School, Boston.
Rainer Krebs, MSc, PhD. 2014. VEGF-A and VEGF-C in Experimental Obliterative Bronchiolitis. Opponent Professor Kathryn Wood, University of Oxford, Oxford, UK.
Mikko Keränen, MD, PhD. 2014. Hypoxia-inducible Factor-1 in Heart Transplantation. Opponent Professor Lorie J. West, University of Alberta, Alberta, Canada.
Antti Nykänen, MD, PhD. 2007. Vascular growth factors and progenitor cells in cardiac allograft arteriosclerosis. Approved with distinction. Opponent Professor Göran Hansson, Karolinska Institute, Stockholm.
Jussi Tikkanen, MD, PhD. 2003. Identification and inhibition of specific pathways leading to transplant obliterative bronchiolitis - an experimental approach in the rat. Opponent Hannah Valentine, Stanford University, Palo Alto, CA.
Roope Sihvola, MD, PhD. 2003. Platelet-Derived Growth Factor and Proinflammatory Cytokines in Cardiac Allograft Arteriosclerosis. Opponet Professor Seppo Ylä-Herttuala, University of Eastern Finland.
Erkki Kallio, MD, PhD. 2000. Pathogenesis of obliterative bronchiolitis in heterotopic rat tracheal allografts. An experimental approach to chronic lung allograft rejection. Approved with distinction. Opponent Professor Sir Magdi Yacoub, Imperial College London, UK.